Tiziana Life Sciences Ltd 6-K Filing

From the Filing

EDGAR Filing Documents for 0001213900-26-037988 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001213900-26-037988 Filing Date 2026-04-01 Accepted 2026-04-01 07:00:01 Documents 3 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 REPORT OF FOREIGN PRIVATE ISSUER ea0284539-6k_tiziana.htm 6-K 14339 2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED APRIL 1, 2026 ea028453901ex99-1.htm EX-99.1 12756 3 GRAPHIC ea028453901_ex99-1img1.jpg GRAPHIC 12597 Complete submission text file 0001213900-26-037988.txt 45782 Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379 Tiziana Life Sciences Ltd (Filer) CIK : 0001723069 (see all company filings) EIN. : 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 26824645 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)